XAGE (Longevity Health Holdings) Revenue: $1.80 Mil (TTM As of Mar. 2026)


XAGE Longevity Health Holdings Inc XAGE
6 GF Score
Price $0.26
! 3 Warning Signs
View Full Analysis

What is Longevity Health Holdings Revenue?

Longevity Health Holdings XAGE 6 Revenue is $1.80 Mil as of Mar. 2026. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review.

Longevity Health Holdings's revenue for the three months ended in Mar. 2026 was $0.39 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1.80 Mil. Longevity Health Holdings's Revenue per Share for the three months ended in Mar. 2026 was $0.21. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.14.

During the past 12 months, the average Revenue per Share Growth Rate of Longevity Health Holdings was 93.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Longevity Health Holdings  (OTCPK:XAGE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Longevity Health Holdings Revenue Related Terms


Longevity Health Holdings Revenue Historical Data

* Premium members only.

The historical data trend for Longevity Health Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Health Holdings Revenue Chart

Longevity Health Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
0.00 0.00 0.00 0.05 1.91

Longevity Health Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.50 0.43 0.47 0.39

XAGE vs SNBH, SKVI, PG: Revenue Comparison

For the Household & Personal Products subindustry, Longevity Health Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Health Holdings Revenue vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Longevity Health Holdings's Revenue falls into.


XAGE
6GF Score
Longevity Health Holdings Inc XAGE
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longevity Health Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $1.80 Mil mean?
Longevity Health Holdings (XAGE) has a Revenue of $1.80 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Longevity Health Holdings and its competitors.
Is Longevity Health Holdings' Revenue too high?
Longevity Health Holdings' current Revenue is $1.80 Mil. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' Revenue compare to SNBH and SKVI?
Longevity Health Holdings' Revenue of $1.80 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Consumer Packaged Goods company?
A good Revenue depends on the Consumer Packaged Goods industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Longevity Health Holdings and its competitors. Longevity Health Holdings's current Revenue is $1.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current Revenue of $1.80 Mil. The current Revenue is $1.80 Mil. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current Revenue is $1.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Health Holdings Business Description

Address 2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
6GF Score

Get the complete analysis for XAGE

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price